angiotensinogen has been researched along with carboprostacyclin* in 1 studies
1 other study(ies) available for angiotensinogen and carboprostacyclin
| Article | Year |
|---|---|
Evidence for a novel regulatory pathway activated by (carba)prostacyclin in preadipose and adipose cells.
Prostacyclin, one of the major prostanoids generated in adipose tissue, has been previously described as an autocrine/paracrine adipogenic effector, acting, in preadipose cells, by means of cAMP and free Ca2+ as cell surface receptor-mediated messengers. The present study presents evidence for the first time that its stable analogue, carbaprostacyclin, is unique among prostanoids in regulating the expression of two differentiation-dependent genes in preadipose and adipose cells in a way distinct from that elicited by its cell surface receptor. This regulation is likely mediated by some member(s) of the peroxisome proliferator-activated receptor family and suggests that prostacyclin behaves as an intracrine effector of adipose cell differentiation. Topics: 3T3 Cells; Adipocytes; Angiotensinogen; Animals; Carrier Proteins; Cell Differentiation; Cell Line; Dexamethasone; Dose-Response Relationship, Drug; Epoprostenol; Fatty Acid-Binding Protein 7; Fatty Acid-Binding Proteins; Gene Expression Regulation; Hormone Antagonists; Mice; Mifepristone; Myelin P2 Protein; Neoplasm Proteins; Nerve Tissue Proteins; Prostaglandins; Receptors, Epoprostenol; Receptors, Prostaglandin; RNA, Messenger | 1996 |